ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2746

A Novel Autoinflammatory Disorder Characterized By Ectodermal Dysplasia, Metaphyseal Chondrodysplasia, Growth Failure and Hyper-IgD In a Single Family

Edward J. Oberle1,2 and James W. Verbsky1,3, 1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, 2Rheumatology, Children's Hospital of Wisconsin, Milwaukee, WI, 3Children's Hospital of Wisconsin, Milwaukee, WI

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Autoinflammatory Disease and genetic disorders

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases II: Autoinflammatory Syndromes

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Autoinflammatory disorders are characterized by chronic inflammation, and a variety of systemic complaints.  Defects in the NF-kb essential modifier, or NEMO, are associated with an immune deficiency characterized by ectodermal dysplasia.  We present a novel autoinflammatory disorder following an autosomal dominant pattern characterized by chronic inflammation, metaphyseal chondrodysplasia, ectodermal dysplasia with hypohidrosis, hyper-IgD and growth failure not associated with immune deficiency in a family. 

Methods:   Seven individuals from one family were identified.  The proband, a male patient age 12 with known hypohydrosis, presented to our rheumatology clinic for chronic articular pain with bony hypertrophy of wrists, knees, and ankles.  Standard labs were obtained including ESR, CRP, and CBC for all affected individuals.  Plain radiographs and immunoglobulins were obtained from patient, father and sister.  Films reviewed by two musculoskeletal radiologists.  The proband underwent proximal tibial bone biopsy and marrow aspirate, as well as genetic testing for known autoinflammatory disorders. 

Results:   The proband, his father age 30, two brothers age 7 and 9, and his 2-year-old sister were all found to have ectodermal dysplasia, short stature and failure to thrive (Figure 1).  The youngest affected was evaluated for fevers and elevated inflammatory markers from birth.  The patient’s father was admitted as a child for bone issues.  All affected members exhibited chronically elevated ESR ranging between 64-118 mm/hr and elevated WBC. Radiographs of proband displayed symmetric lucent and sclerotic lesions of the metaphysis of distal radius/ulna, distal femora, and proximal and distal tibia/fibula (Figure 2).  His father demonstrated widened metaphyses of distal ulna and tibia, but did not have lesions.  Immunoglobulins were elevated in the patient and his father with IgD levels of 755 mg/L (<179 normal) and 600 mg/L, respectively.  Bone biopsy of the proband was consistent with metaphyseal chondrodysplasia with marrow spaces consisting of loose fibrous stroma or cartilage, with scattered lymphocytes and plasmacytoid cells.  Genetic testing was negative for mutations of CIAS1, LPIN2, MVK, IKBKG (NEMO), PSTP1P1, and TRAPS.

Conclusion: We propose a novel, autoinflammatory disorder resulting in osseous abnormalities, ectodermal dysplasia and Hyper IgD.

Figure 1.  Pedigree.

Figure 2.  Proband radiographs.

 


Disclosure:

E. J. Oberle,
None;

J. W. Verbsky,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-autoinflammatory-disorder-characterized-by-ectodermal-dysplasia-metaphyseal-chondrodysplasia-growth-failure-and-hyper-igd-in-a-single-family/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology